These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 25903787)

  • 1. SomInaClust: detection of cancer genes based on somatic mutation patterns of inactivation and clustering.
    Van den Eynden J; Fierro AC; Verbeke LP; Marchal K
    BMC Bioinformatics; 2015 Apr; 16():125. PubMed ID: 25903787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of constrained cancer driver genes based on mutation timing.
    Sakoparnig T; Fried P; Beerenwinkel N
    PLoS Comput Biol; 2015 Jan; 11(1):e1004027. PubMed ID: 25569148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and analysis of mutational hotspots in oncogenes and tumour suppressors.
    Baeissa H; Benstead-Hume G; Richardson CJ; Pearl FMG
    Oncotarget; 2017 Mar; 8(13):21290-21304. PubMed ID: 28423505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Machine Learning Classification and Structure-Functional Analysis of Cancer Mutations Reveal Unique Dynamic and Network Signatures of Driver Sites in Oncogenes and Tumor Suppressor Genes.
    Agajanian S; Odeyemi O; Bischoff N; Ratra S; Verkhivker GM
    J Chem Inf Model; 2018 Oct; 58(10):2131-2150. PubMed ID: 30253099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational patterns in oncogenes and tumour suppressors.
    Baeissa HM; Benstead-Hume G; Richardson CJ; Pearl FM
    Biochem Soc Trans; 2016 Jun; 44(3):925-31. PubMed ID: 27284061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IDENTIFY CANCER DRIVER GENES THROUGH SHARED MENDELIAN DISEASE PATHOGENIC VARIANTS AND CANCER SOMATIC MUTATIONS.
    Ma M; Wang C; Glicksberg BS; Schadt EE; Li SD; Chen R
    Pac Symp Biocomput; 2017; 22():473-484. PubMed ID: 27896999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of signals of positive and negative selection to distinguish cancer genes and passenger genes.
    Bányai L; Trexler M; Kerekes K; Csuka O; Patthy L
    Elife; 2021 Jan; 10():. PubMed ID: 33427197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remarkable difference of somatic mutation patterns between oncogenes and tumor suppressor genes.
    Liu H; Xing Y; Yang S; Tian D
    Oncol Rep; 2011 Dec; 26(6):1539-46. PubMed ID: 21887471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Gene polymorphisms].
    Robert J
    Bull Cancer; 2010 Nov; 97(11):1253-64. PubMed ID: 21115419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Towards an inventory of oncogenic mutations in cancer].
    Theillet C
    Bull Cancer; 2010 Nov; 97(11):1223-9. PubMed ID: 21059490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of new driver and passenger mutations within APOBEC-induced hotspot mutations in bladder cancer.
    Shi MJ; Meng XY; Fontugne J; Chen CL; Radvanyi F; Bernard-Pierrot I
    Genome Med; 2020 Sep; 12(1):85. PubMed ID: 32988402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatic selection distinguishes oncogenes and tumor suppressor genes.
    Chandrashekar P; Ahmadinejad N; Wang J; Sekulic A; Egan JB; Asmann YW; Kumar S; Maley C; Liu L
    Bioinformatics; 2020 Mar; 36(6):1712-1717. PubMed ID: 32176769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Copy number losses of oncogenes and gains of tumor suppressor genes generate common driver mutations.
    Besedina E; Supek F
    Nat Commun; 2024 Jul; 15(1):6139. PubMed ID: 39033140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenes and tumor suppressor genes: comparative genomics and network perspectives.
    Zhu K; Liu Q; Zhou Y; Tao C; Zhao Z; Sun J; Xu H
    BMC Genomics; 2015; 16 Suppl 7(Suppl 7):S8. PubMed ID: 26099335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatic mutation distribution across tumour cohorts provides a signal for positive selection in cancer.
    Boström M; Larsson E
    Nat Commun; 2022 Nov; 13(1):7023. PubMed ID: 36396655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A CATH domain functional family based approach to identify putative cancer driver genes and driver mutations.
    Ashford P; Pang CSM; Moya-García AA; Adeyelu T; Orengo CA
    Sci Rep; 2019 Jan; 9(1):263. PubMed ID: 30670742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying cancer type specific oncogenes and tumor suppressors using limited size data.
    Pavel AB; Vasile CI
    J Bioinform Comput Biol; 2016 Dec; 14(6):1650031. PubMed ID: 27712196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncogenes and tumor suppressor genes.
    Carbone DP
    Hosp Pract (Off Ed); 1993 Jun; 28(6):145-8, 153-6, 161. PubMed ID: 8509476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statistically identifying tumor suppressors and oncogenes from pan-cancer genome-sequencing data.
    Kumar RD; Searleman AC; Swamidass SJ; Griffith OL; Bose R
    Bioinformatics; 2015 Nov; 31(22):3561-8. PubMed ID: 26209800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Current topics in mutations in the cancer genome].
    Iwaya T; Mimori K; Wakabayashi G
    Nihon Geka Gakkai Zasshi; 2012 Mar; 113(2):185-90. PubMed ID: 22582578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.